JOCELYNN CASSELLE: Open Payments
NPI 1174959704 · LARGO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 11 payments from 9 companies in 2025. Trend: 2023 $1,365 · 2024 $756 · 2025 $1,027
Food & beverage: $1,027
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $201 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $168 |
| Dexcom, Inc. | 1 | $135 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $117 |
| Hologic Sales and Service, LLC | 1 | $110 |
| Insmed, Inc. | 1 | $93 |
| Solventum Corporation | 1 | $55 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
Products named: DEXCOM G7 GSS (161), NEFFY, INGREZZA, APTIMA, Arikayce, ACTIV.A.C., Exparel.
Industry payments across MD — which companies pay providers there.
